A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous cell lung cancer (SqCLC) previously treated with platinum-based chemotherapy.

被引：1
|
作者：
Scagliotti, Giorgio V.
Govindan, Ramaswamy
Hurt, Karla
Chiang, Alan
机构：
[1] Univ Turin, Turin, Italy
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Eli Lilly, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.TPS9101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9101
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous non-small cell lung cancer (sqNSCLC) previously treated with platinum-based chemotherapy.
    Scagliotti, Giorgio V.
    Bondarenko, Igor
    Ciuleanu, Tudor-Eliade
    Bryl, Maciej
    Fulop, Andrea
    Vicente, David
    Bischoff, Helge
    Hurt, Karla
    Lu, Yi
    Estrem, Shawn
    Wijayawardana, Sameera R.
    Chiang, Alan
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy.
    Felip, Enriclueta
    Rojo, Federico
    Reck, Martin
    Heller, Astrid
    Klughammer, Barbara
    Sala, Gemma
    Cedres, Susana
    Peralta, Sergio
    Maacke, Heiko
    Foernzler, Dorothee
    Parera, Marta
    Moecks, Joachim
    Saura, Cristina
    Gatzemeier, Ulrich
    Baselga, Jose
    CLINICAL CANCER RESEARCH, 2008, 14 (12) : 3867 - 3874
  • [3] Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    Shepherd, FA
    Dancey, J
    Ramlau, R
    Mattson, K
    Gralla, R
    O'Rourke, M
    Levitan, N
    Gressot, L
    Vincent, M
    Burkes, R
    Coughlin, S
    Kim, Y
    Berille, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) : 2095 - 2103
  • [4] Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    Esteban, E
    de Sande, LG
    Fernández, Y
    Corral, N
    Fra, J
    Muniz, I
    Vieitez, JM
    Palacio, I
    Fernández, JL
    Estrada, E
    Lacave, AJ
    ANNALS OF ONCOLOGY, 2003, 14 (11) : 1640 - 1647
  • [5] Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
    Leu, KM
    Kim, KM
    Larson, M
    Larson, M
    Schiller, JH
    LUNG CANCER, 2001, 34 (01) : 105 - 113
  • [6] Randomized Phase III Trial of Gefitinib versus Docetaxel in Non-Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy
    Lee, Dae Ho
    Park, Keunchil
    Kim, Joo Hang
    Lee, Jong-Seok
    Shin, Sang Won
    Kang, Jin-Hyoung
    Ahn, Myung-Ju
    Ahn, Jin Seok
    Suh, Cheolwon
    Kim, Sang-We
    CLINICAL CANCER RESEARCH, 2010, 16 (04) : 1307 - 1314
  • [7] A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503
    Segawa, Yoshihiko
    Kiura, Katsuyuki
    Hotta, Katsuyuki
    Takigawa, Nagio
    Tabata, Masahiro
    Matsuo, Keitaro
    Yoshioka, Hiroshige
    Hayashi, Hidetoshi
    Kawai, Haruyuki
    Aoe, Keisuke
    Maeda, Tadashi
    Ueoka, Hiroshi
    Tanimoto, Mitsune
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1430 - 1434
  • [8] Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group
    Pectasides, D
    Fountzilas, G
    Rigopoulos, A
    Bountouroglou, NG
    Koutras, A
    Glotsos, J
    Onyenadum, A
    Makatsoris, T
    Kalofonos, HP
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3501 - 3506
  • [9] Randomized pharmacokinetic evaluation of subcutaneous versus intravenous administration of granisetron in cancer patients treated with platinum-based chemotherapy.
    Perez-Gracia, J.
    Sadaba, B.
    Lopez-Picazo, J.
    Azanza Perea, J.
    Cabello, J.
    Campanero Martinez, M.
    Martin Algarra, S.
    Gil-Aldea, I.
    Garcia-Foncillas, J.
    Gurpide, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 482S - 482S
  • [10] Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy - A phase II trial
    Tas, F
    Demir, C
    Camlica, H
    Ustuner, Z
    Topuz, E
    MEDICAL ONCOLOGY, 2004, 21 (03) : 233 - 240
12345